Japanese wholesalers join up in $2b deal

As was rumored yesterday, Japan's biggest drug wholesaler, Mediceo Paltac, plans a buyout of its closest rival Alfresa in a $2 billion deal that will create a company more than twice as large of its next largest competitor. Report

Suggested Articles

CSL has sued a former exec who its says stole thousands of key documents as he left for competitor Pharming.

Private equity player Ampersand Capital Partners is backing another CDMO, this one targeted at sterile injectables.

How much are lawsuits hurting J&J's brand? The New Jersey drugmaker has lost half a billion dollars in brand value over the past year, a report says.